• Providing heretofore unavailable objective information, affording the opportunity for an earlier, more accurate and precise diagnosis.
• Providing physicians another scientifically proven modality to assist them with soft tissue pathology assessment.
• Providing data for site-specific physical therapy.
• Allowing comparison studies assessing progress in rehabilitation programs.
• Providing objective data to assist physicians with MMI and P&S determinations.

Soft tissue (STI) and repetitive stress injuries (RTI) traditionally have been evaluated via clinical examination by the primary care physician. In some cases, subsequent assessment by methods such as MRIs, functional strength/capacity tests (FCE), nerve conduction studies and needle electromyography are performed by a neurologist or physician in a related specialty.

The diagnostic accuracy of the above listed evaluations of soft tissue injuries has proven to be elusive to the medical community, costly to the employers and insurers and frustrating to the injured parties.

These existing diagnostic methods alone are, in many cases, not comprehensive enough for assessing patients with or at risk for soft tissue injuries and ailments. They are static and not designed to assess muscle function dynamically (while a patient is in motion). They cannot determine conclusively the clinical significance of pathology or correlate findings with the injured worker's/patient's subjective complaints.

The results provided by the prevailing methods are vulnerable to different interpretations, which leads to inter-reader variability and lack of objectivity.

MED-TEK recently completed a three year campaign with the primary goals to introduce, create utilization and quantify results from CMAP™ testing to empirically demonstrate to employers, TPAs and insurance companies the ability of CMAP™ to objectively and accurately quantify the veracity, location and severity of soft tissue injuries. In addition, MED-TEK subjected CMAP™ to clinical trials and independent retrospective analysis. Results have been published in occupational health peer reviewed journals: Journal of Occupational Rehabilitation Q’1 2009, Practical Pain Management, March 2009 and a retrospective analysis accepted for publication in the Journal of Applied Biobehavioral Research Q’3 2009. These positive results have enabled CMAP™ to gain acceptance and traction with the medical community.

CMAP™ enables physicians to quantify the veracity and severity of soft tissue injuries objectively and accurately with data based results. This corroborates (or alters) the diagnosis of the patient’s physicians. Its results are objective and precise, evidence based, medically relevant, reproducible and defensible in court. The most salient and unique feature of CMAP™ is that it affords physicians an objective means to measure impairment as it pertains to functional capacity and range of motion.

Independent statistical analysis has demonstrated that utilization of CMAP™ suite of evaluations has provided clear improvement in clinical outcome.